title: Optimal treatment of retinal angiomatous proliferation.
authors.forename: Lazaros
authors.initials: L
authors.lastname: Konstantinidis
authors.forename: Leonidas
authors.initials: L
authors.lastname: Zografos
authors.forename: Irmela
authors.initials: I
authors.lastname: Mantel
authors.forename: Aude
authors.initials: A
authors.lastname: Ambresin
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000798:Angiomatosis / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D000069579:Ranibizumab; D012164:Retinal Diseases / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab
references.citation: Retina. 2009 Apr;29(4):536-44
references.pmid: 19190547
references.citation: Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1165-71
references.pmid: 19404661